- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2020-01-17 16:06:29
- Reporting Period:
- Accepted Time:
- 2020-01-17 16:06:29
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1103021||Biodelivery Sciences International Inc||BDSI||Pharmaceutical Preparations (2834)||352089858|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1720772||Theresa Mary Coelho||C/o Biodelivery Sciences Intl, Inc. |
4131 Parklake Ave. Suite 225
Raleigh NC 27612
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Restricted Stock Units||Disposition||2020-01-15||18,333||$0.00||18,333||$0.00|
|Common Stock||Stock Options (right to buy)||Disposition||2020-01-15||35,703||$3.73||35,703||$3.73|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan.
- On January 16, 2020, the Reporting Person sold an aggregate of 42,018 shares of the Issuer's Common Stock at a weighted average price of $5.98 per share. The highest sale price for the Common Stock was $6.00 per share and the lowest sale price was $5.89 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest in equal portions on: (i) January 15, 2021; and (ii) January 15, 2022.
- The shares of common stock were acquired by the Reporting Person as a result of the exercise of stock options granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the stock options under this grant vest in equal portions on: (i) January 15, 2021; and (ii) January 15, 2022.